Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
P
4701
Everpure Inc
P
$27.8B
| $124K | ﹤0.01% |
7,725
+6,332
| +455% | +$86.8K |
|
4702
Star Bulk Carriers
SBLK
$3.12B
| $124K | ﹤0.01% |
12,849
+11,421
| +800% | +$119K |
|
|
NEWR
4703
DELISTED
New Relic, Inc.
NEWR
| $124K | ﹤0.01% |
2,489
+2,422
| +3,615% | +$114K |
|
|
ACOR
4704
DELISTED
Acorda Therapeutics
ACOR
| $124K | ﹤0.01% |
44
-6
| -12% | -$15.8K |
|
|
AAWW
4705
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $124K | ﹤0.01% |
1,880
-3,213
| -63% | -$201K |
|
|
JMBA
4706
DELISTED
Jamba, Inc.
JMBA
| $124K | ﹤0.01% |
14,246
-1,138
| -7% | -$10.1K |
|
|
MTGE
4707
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $124K | ﹤0.01% |
6,366
-8,171
| -56% | -$156K |
|
4708
CALL
Albemarle
ALB
$14B
| $123K | ﹤0.01% |
900
+600
| +200% | +$71.3K |
|
|
AMED
4709
CALL
DELISTED
Amedisys
AMED
| $123K | ﹤0.01% |
2,200
+1,200
| +120% | +$63.5K |
|
|
BECN
4710
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $123K | ﹤0.01% |
2,401
+2,356
| +5,236% | +$110K |
|
|
NWLI
4711
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $123K | ﹤0.01% |
353
+249
| +239% | +$83.6K |
|
|
DRYS
4712
DELISTED
DryShips Inc. Common Stock
DRYS
| $123K | ﹤0.01% |
+50,000
| New | +$159K |
|
4713
Heritage Financial
HFWA
$1.23B
| $122K | ﹤0.01% |
4,155
+4,033
| +3,306% | +$108K |
|
4714
Pricesmart
PSMT
$5.76B
| $122K | ﹤0.01% |
1,367
+395
| +41% | +$33.1K |
|
4715
TechTarget
TTGT
$317M
| $122K | ﹤0.01% |
10,254
+439
| +4% | +$4.48K |
|
4716
ProShares Ultra Real Estate
URE
$60.4M
| $122K | ﹤0.01% |
1,908
+250
| +15% | +$15.9K |
|
|
RETA
4717
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $122K | ﹤0.01% |
3,928
+3,734
| +1,925% | +$112K |
|
|
ORBK
4718
DELISTED
Orbotech Ltd
ORBK
| $122K | ﹤0.01% |
2,884
+129
| +5% | +$4.93K |
|
|
KND
4719
DELISTED
Kindred Healthcare
KND
| $122K | ﹤0.01% |
17,988
-20,873
| -54% | -$178K |
|
4720
PUT
Calumet Specialty Products
CLMT
$3.62B
| $121K | ﹤0.01% |
14,500
+14,200
| +4,733% | +$88.5K |
|
4721
CALL
IDEX
IEX
$17.5B
| $121K | ﹤0.01% |
1,000
| – | – |
|
|
ACET
4722
DELISTED
Aceto Corp
ACET
| $121K | ﹤0.01% |
10,752
+4,960
| +86% | +$68.4K |
|
4723
Aurinia Pharmaceuticals
AUPH
$1.95B
| $120K | ﹤0.01% |
19,100
+16,300
| +582% | +$103K |
|
4724
CALL
Expeditors International
EXPD
$23.6B
| $120K | ﹤0.01% |
2,000
-1,200
| -38% | -$68.7K |
|
|
FONR
4725
DELISTED
Fonar
FONR
| $120K | ﹤0.01% |
3,941
+136
| +4% | +$3.84K |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.